Research

November 20, 2014

Receptor discovery shines new light on appetite regulation

A receptor in the brain that regulates appetite and body weight has now been found in L cells, key regulatory cells in the gut, providing the pharmaceutical industry with a novel drug target for both obesity and diabetes, a Vanderbilt University-led research team reported this week.

By Bill Snyder
November 19, 2014

More breast cancer patients opting for mastectomy, Vanderbilt study finds

By VUMC News and Communications
chip closeup
November 18, 2014

Vanderbilt’s neurovascular chip project moves into new phase

Vanderbilt researchers will play a key role in the second phase of the federal “tissue chip for drug screening” program.

By VUMC News and Communications
two nuclear plant silos
November 13, 2014

Vanderbilt team examines human factors in nuclear power plant operations

A multidisciplinary Vanderbilt team with deep experience in improving patient safety and technology usability has received a three-year, $800,000 Department of Energy grant to help nuclear power plant operators better perform their jobs.

By VUMC News and Communications
November 13, 2014

Grant bolsters inguinal hernia repair research

Martin Blakely, M.D., M.S., has been awarded a $3 million federal grant for a multi-center, multi-disciplinary study to examine the safety outcomes of early versus later inguinal hernia repair for premature infants.

By Christina Echegaray
November 13, 2014

Standardized social, behavioral data key to EHR success

In recent years the federal government has used financial incentives and penalties to promote use of electronic health records (EHR), but in these regulations the issue of EHR data interoperability — that is, data standardization — has been left largely unresolved, dimming prospects for data exchange, population health surveillance and systematic improvement across health networks.

By Paul Govern
November 13, 2014

Physical therapy helps ease vocal muscle imbalances

For singers who suddenly can’t hit their high notes or call center workers who develop pain while speaking, physical therapy may offer new treatment solutions.
By VUMC News and Communications
November 12, 2014

New insight on oral cancer culprits

A new mouse model offers insight into the signaling pathways that control oral cancers – and a platform for testing anticancer therapeutics.
By Elizabeth Conrad
November 11, 2014

Protein “pockets” help ID cancer genes

Vanderbilt investigators have used a computational biology approach to uncover new cancer drivers and biomarkers of anticancer drug response.
By Bill Snyder
November 7, 2014

Overactive stress response in obesity

An overactive stress response contributes to the development of insulin resistance in obese individuals, and blocking it may be therapeutically beneficial.
By VUMC News and Communications
November 6, 2014

Immune cell activity and melanoma

The activity of a certain factor in immune cells is essential for an anti-tumor response, emphasizing the need to consider the effects of anti-cancer therapies on immune cells.
By VUMC News and Communications
November 6, 2014

BioVU to collect plasma in hunt for heart failure clues

Vanderbilt’s biobank, BioVU, has begun to collect and store plasma, the liquid part of blood, to aid studies of diseases ranging from heart failure and hypertension to breast cancer.
By Bill Snyder
November 6, 2014

Optogenetics sheds new light on brain’s behavior modulators

A new light-based technology is allowing scientists to peer deep into the brain and alter animal behavior with the “flip of a switch.”
By VUMC News and Communications
1 … 135 136 137 138 139 … 210